Approval · Notice of Compliance 37926 · 2026
VTRS-ELETRIPTAN: Notice of Compliance 37926
Issued July 16, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37926
- Date
- July 16, 2026
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in product name
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VTRS-ELETRIPTAN | 02342235 | Marketed |
| VTRS-ELETRIPTAN | 02342243 | Marketed |
Medicinal ingredients
- ELETRIPTAN HYDROBROMIDE 20 MG per TAB
- ELETRIPTAN HYDROBROMIDE 40 MG per TAB